Connection
Brian Freed to Hydroquinones
This is a "connection" page, showing publications Brian Freed has written about Hydroquinones.
|
|
Connection Strength |
|
|
|
|
|
0.786 |
|
|
|
-
McCue JM, Lazis S, John Cohen J, Modiano JF, Freed BM. Hydroquinone and catechol interfere with T cell cycle entry and progression through the G1 phase. Mol Immunol. 2003 Jun; 39(16):995-1001.
Score: 0.231
-
Li Q, Kasten-Jolly J, Yen Y, Freed BM. Reversal of hydroquinone-mediated suppression of T cell proliferation by transfection of the M2 subunit of ribonucleotide reductase. Toxicol Appl Pharmacol. 1998 May; 150(1):154-7.
Score: 0.162
-
Li Q, Aubrey MT, Christian T, Freed BM. Differential inhibition of DNA synthesis in human T cells by the cigarette tar components hydroquinone and catechol. Fundam Appl Toxicol. 1997 Aug; 38(2):158-65.
Score: 0.154
-
Li Q, Geiselhart L, Mittler JN, Mudzinski SP, Lawrence DA, Freed BM. Inhibition of human T lymphoblast proliferation by hydroquinone. Toxicol Appl Pharmacol. 1996 Aug; 139(2):317-23.
Score: 0.144
-
McCue JM, Link KL, Eaton SS, Freed BM. Exposure to cigarette tar inhibits ribonucleotide reductase and blocks lymphocyte proliferation. J Immunol. 2000 Dec 15; 165(12):6771-5.
Score: 0.049
-
Ouyang Y, Virasch N, Hao P, Aubrey MT, Mukerjee N, Bierer BE, Freed BM. Suppression of human IL-1beta, IL-2, IFN-gamma, and TNF-alpha production by cigarette smoke extracts. J Allergy Clin Immunol. 2000 Aug; 106(2):280-7.
Score: 0.047
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|